Salute e Benessere

Minutes of Annual General Meeting 2024

All the matters on the agenda were approved and the minutes of the Annual General Meeting are attached to this release and are available on www.pcibiotech.com.Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CEO / CFO, rs@pcibiotech.no, Mobile: +47 9400 5757This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act. Attachment PCI Biotech Holding ASA...
Nasdaq GlobeNewswire
24/05/2024

Menarini Group Presents Updated Data from ELECTRA and ELEVATE Combination…

The ELECTRA study is evaluating elacestrant in combination with abemaciclib in patients with ER+, HER2- metastatic breast cancer with brain metastases; however, the phase 1b portion of this study was conducted in all metastatic sites, including brain metastases. The updated phase 1b results continue to show a satisfactory safety profile, consistent with prior findings, and promising activity in patients with ER+, HER2- advanced or mBC regardless of metastatic site. Based on the results…
PR Newswire
24/05/2024

STORM Therapeutics to Present Interim Phase 1 Clinical Data on its METTL3 RNA…

CAMBRIDGE, England, May 24, 2024 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announces that it will be presenting interim clinical data on its first-in-class lead product, STC-15 at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago, US from May 31 to June 4, 2024. CAMBRIDGE, England,May 24, 2024/PRNewswire/ -- STORM Therapeutics…
PR Newswire
24/05/2024

Lift BioSciences Announces Abstract Publications at the American Society of…

Lift BioSciences Announces Abstract Publications at the American Society of Clinical Oncology (ASCO) Annual MeetingLondon, 24 May 2024– LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech company about to start clinical trials for its first-in-class allogeneic innate cell therapy, today announces the publication of two online abstracts at the annual American Society of Clinical Oncology, to be held from 31 May to 4 June 2024 in McCormick Place Convention Centre in...
Nasdaq GlobeNewswire
24/05/2024

Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024

Press ReleaseNicox: 2024 Ordinary Shareholder Meeting to be held on June 28 th, 2024May 24, 2024 – release at 7:30 am CETSophia Antipolis, France Nicox SA(Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, convenes an ordinary shareholder meeting onFriday June 28 th, 2024 at 2:30 pm CESTin the offices of BuroClub – Drakkar 2 – Bâtiment D – 2405 route des Dolines – 06560 Valbonne Sophia Antipolis – France.The documents...
Nasdaq GlobeNewswire
24/05/2024

ONCOCLÍNICAS APPROVES R$ 1.5 BILLION CAPITAL INCREASE

This capital increase complies with the ceiling established within the company's Articles of Association and does not require any statutory change. The capital increase will be carried out through the issuance of 115.4 million new registered ordinary shares with no par value. This capital increase complies with the ceiling established within the company's Articles of Association and does not require any statutory change. The capital increase will be carried out through the issuance of 115...
PR Newswire
24/05/2024

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine…

EVX-01 induced positiveclinically relevant immune responses in all assessed patientsBooster immunizations tended to increase the immune responseThe observed immune responses were mediated by both CD4+ and CD8+ T-cellsCOPENHAGEN, Denmark, May23, 2024(GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announces its participation in the American...
Nasdaq GlobeNewswire
23/05/2024

Genmab to Showcase Data in Various Patient Populations to be Presented at the…

Media ReleaseCOPENHAGEN, Denmark; May 23, 2024 Six oral and poster presentations will highlight breadth of clinical program and potential utility of epcoritamab-bysp in patients with difficult-to-treat lymphomas across multiple lines of therapy and histologies where high unmet needs existResults from two studies evaluating tisotumab vedotin in patients with head and neck squamous cell carcinoma and recurrent or metastatic cervical cancer accepted for oral and poster presentations,...
Nasdaq GlobeNewswire
23/05/2024

Philips successfully prices offering of Notes for EUR 700 million to be used for…

Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 700 million fixed rate notes due 2032 (the “Notes”) under its European Medium Term Note (EMTN) program.The issue of the Notes will have a debt-neutral effect, as the net proceeds of the transaction will be used for repayment of debt in 2024 and 2025.The issue price for the Notes is 98.257% with a Coupon of 3...
Nasdaq GlobeNewswire
23/05/2024

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference

PARIS and CAMBRIDGE, Mass., May23, 2024(GLOBE NEWSWIRE) --NANOBIOTIX(Euronext: NANO –– NASDAQ: NBTX – the '' Company ''), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced today that Company management will participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference. Please see below for details of the event. Jefferies Global Healthcare Conference Date:...
Nasdaq GlobeNewswire
23/05/2024

Zealand Pharma announces topline results from the mechanistic investigator-led…

Company announcement – No. 27 / 2024 Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutideMean weight loss of up to 4.3% after 12 weeks with low doses of dapiglutide treatment Dapiglutide was assessed to be well-toleratedTolerability profile observed suggests doses investigated were at the lower end of the therapeutic rangeMuch higher doses of dapiglutide are being investigated in...
Nasdaq GlobeNewswire
23/05/2024

Photocure ASA - Annual general meeting held

For further information, please contact: For further information, please contact: Photocure CFOErik DahlTel: + 47 450 55 000 Email:ed@photocure.no About Photocure ASA Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered inOslo, Norway, and listed on the...
PR Newswire
23/05/2024

Hornet Therapeutics emerges from stealth with data published in Science…

Press ReleaseHornet Therapeutics emerges from stealth with data published inSciencedemonstrating the first potential drug intervention for Epstein-Barr Virus (EBV) driven disease 4BIO Capital incubated company launches with the first ever small molecule drug that has potential for treating EBV-driven diseasesNew data demonstrates decreased EBV latency upon inhibition of the host metabolic enzyme IDO-1 in target cellsThe company emerges from stealth with a strategic...
Nasdaq GlobeNewswire
23/05/2024

Oxurion Announces Results on the Annual Shareholders' Meeting of 16 May 2024

Oxurion Announces Results on the Annual Shareholders' Meeting of 16 May 2024 Leuven, BELGIUM – 23 May, 2024 – 07.00 PM CET– Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, held its annual shareholders' meeting on May 16, 2024. The shareholders approved all items on the agenda of the annual shareholders' meeting.All documents pertaining to the annual shareholders' meeting held on May 16, 2024, can be consulted on Oxurion's website...
Nasdaq GlobeNewswire
23/05/2024

Global Sugar Alcohol Market to Scale Beyond $2.46 Billion with 5.9% CAGR by 2034…

Consumption of food and drinks prepared with sugar alcohols rather than ordinary sugar is rising due to the rising prevalence of diabetes, as these products are detrimental to those who already have such a condition. A lot of people have begun using sugar alcohol to manage their weight and blood sugar levels. Sugar alcohols are becoming popular replacements for sucrose and high-fructose corn syrup because they add sweetness without having the same negative metabolic effects. Consumption of…
PR Newswire
23/05/2024

Sequana Medical announces results of Annual and Extraordinary General Meetings…

PRESS RELEASE REGULATED INFORMATION23 May 2024, 06:00 pm CESTGhent, Belgium – 23 May 2024– Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that all proposed resolutions submitted to the Annual and Extraordinary General Meetings of Shareholders were approved at the meetings held today at 09:00 am CEST.The items on the agendas of...
Nasdaq GlobeNewswire
23/05/2024

Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival…

Pelareorep, an innovative immunotherapeutic agent developed by Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), is making significant strides in the treatment of various cancers, particularly breast and pancreatic cancer. After securing Fast Track Designation from the FDA for its use in pancreatic cancer in late 2022 due to promising clinical results, the company has initiated a preliminary collaboration with the Global Coalition for Adaptive Research (GCAR). This collaboration focuses on…
PR Newswire
23/05/2024

Healthcare Artificial Intelligence Market to Be Worth $176.4 Billion by 2031 -…

Healthcare is one of the most critical sectors in the broader landscape of big data because of its fundamental role in a productive, thriving society. AI in healthcare is a term used to describe the application of machine learning (ML) algorithms and other cognitive technologies in medical settings. AI helps to assist doctors, nurses, and other healthcare workers in their daily work. AI in healthcare enhances preventive care and quality of life, produces more accurate diagnoses and treatment…
PR Newswire
23/05/2024

Foot Orthotic Insole Market Size is Expected to Reach US$ 9.44 Billion by 2034 |…

More people across the world are experiencing several orthopedic issues such as diabetic foot ulcers, sports injuries, and injuries due to accidents. This factor is contributing to the increasing adoption of foot orthotic insoles. Manufacturers are bolstering their market stance by producing customized insoles as per varied consumer needs. More people across the world are experiencing several orthopedic issues such as diabetic foot ulcers, sports injuries, and injuries due to accidents...
PR Newswire
23/05/2024

Continuous Bioprocessing Market to Be Worth $1.32 Billion by 2031 - Exclusive…

Continuous bioprocessing has become a major trend in biopharmaceutical manufacturing due to its agility, flexibility, efficiency, and robustness. It reduces the number of steps and holds, requires smaller facilities with limited equipment, and improves product quality, enabling real-time release. Advantages such as cost efficiency and improved product quality are expected to drive the adoption of continuous bioprocessing in the biopharmaceutical industry in the coming years. Continuous…
PR Newswire
23/05/2024

Cannabis Testing Market Worth $4.0 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46932450 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46932450 Browse in-depth TOC on "Cannabis Testing Market" 439 - Tables 52 - Figures 378 - Pages Cannabis Testing Market Scope: Products segment held the highest estimated share of the cannabis testing market. Based on product & software, the cannabis testing market is...
PR Newswire
23/05/2024

Wheelchair Cushions Market Size to Hit USD 890.4 Mn by 2031

Market Dynamics: Market Dynamics : The wheelchair cushions market is experiencing significant growth owing to rising incidences of road accidents and chronic diseases such as arthritis. According to the World Health Organization (WHO), road traffic injuries cause around 1.35 million deaths annually. Moreover, as per the Arthritis Foundation, over 54 million adults have been diagnosed with arthritis in the U.S., which is a leading cause of disability. Wheelchair cushions provide comfort and...
PR Newswire
23/05/2024

3D Printing Photopolymer Market Worth USD 2,902.4 Million by 2031 - Exclusive…

The use of 3D printing in industries is commonly referred to as additive manufacturing (AM). With the use of software and a 3-dimensional printer, additive manufacturing comprises the layer-by-layer addition of material to construct an item, referring to a three-dimensional file. Significant use of 3D printing technology in pharmaceutical applications and aerospace & defence parts is anticipated to drive the market. The use of 3D printing in industries is commonly referred to as additive...
PR Newswire
23/05/2024

Veterinary API Market to Be Worth $15.84 Billion by 2031 - Exclusive Report by…

Veterinary APIs are a critical component of the animal healthcare industry. It involves the production of essential compounds for the formation of animal pharmaceuticals/veterinary drugs. These APIs are the biologically active components responsible for the therapeutic effects in animals when they receive medical care. Veterinary APIs are a critical component of the animal healthcare industry. It involves the production of essential compounds for the formation of animal...
PR Newswire
23/05/2024
Altri  Comunicati